Additionally, it has been shown that the SOCE inhibitors, SKF-96365 and 2-APB, or the genetic knockdown of STIM1 and ORAI1 suppress the LPS-induced COX-2 production in gastric cancer cells [31]. The gene discussed is STIM1; the disease is gastric cancer.